Under Major revaluation

Wouldn't be surprised to see this stock break all time highs in next few months and in the next 12-months $50+.

* Key notes: 2nd generation Covid Vaccine sponsored by NIAID that's being conducted through infectious diseases clinical research consortium (IDCRC). Established collaboration with Gilead Sciences to develop a vaccine-based immunotherapy as part of Gilead's efforts to find a 'curative treatment for human immunodeficiency virus" (HIV) infection, and received $60 million in proceeds as part of the collaboration for GRTS HIV candidate. More candidates in clinic on their website.


Very bullish accumulation going on after test of $35 (red horizontal line).

See my other picks! KKMPH VBIV BCRX GGRTS

Disclaimer: This is not a buy or sell recommendation. I am not a financial analyst. This information should be used for educational purposes only.